Faramarzi Mohammad Ali, Aghelnejad Maryam, Tabatabaei Yazdi Mojtaba, Amini Mohsen, Hajarolasvadi Naghmeh
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical Sciences/University of Tehran, Tehran 14174, Iran.
Steroids. 2008 Jan;73(1):13-8. doi: 10.1016/j.steroids.2007.06.008. Epub 2007 Jul 10.
Microbial transformation of androst-4-en-3,17-dione (AD; I) using Neurospora crassa afforded six metabolites; 6beta,14alpha-dihydroxyandrost-4-en-3,17-dione (II), 6beta,9alpha-dihydroxyandrost-4-en-3,17-dione (III), 7alpha-hydroxyandrost-4-en-3,17-dione (IV), 9alpha-hydroxyandrost-4-en-3,17-dione (V), 14alpha-hydroxyandrost-4-en-3,17-dione (VI), and androst-4,6-dien-3,17-dione (VII). The steroid products were assigned by interpretation of their spectral data such as (1)H NMR, (13)C NMR, FTIR, and mass spectroscopy. The characteristic transformations observed were C-6beta, C-7alpha, C-9alpha, C-14alpha hydroxylations, and C6-C7 dehydrogenation. The best fermentation condition was found to be 6-day incubation at 25 degrees C and pH value of 5.0-6.5 according to TLC profiles. Time course study showed the accumulation of V and VI from the third day and IV from the fourth day of the fermentation. Optimum concentration of the substrate, which gave maximum bioconversion efficiency, was 3.5mM in one batch. Biotransformation was completely inhibited in a concentration above 7.0mM.
利用粗糙脉孢菌对雄甾-4-烯-3,17-二酮(AD;I)进行微生物转化,得到了六种代谢产物:6β,14α-二羟基雄甾-4-烯-3,17-二酮(II)、6β,9α-二羟基雄甾-4-烯-3,17-二酮(III)、7α-羟基雄甾-4-烯-3,17-二酮(IV)、9α-羟基雄甾-4-烯-3,17-二酮(V)、14α-羟基雄甾-4-烯-3,17-二酮(VI)以及雄甾-4,6-二烯-3,17-二酮(VII)。通过对其光谱数据(如¹H NMR、¹³C NMR、FTIR和质谱)的解析来确定甾体产物。观察到的特征转化包括C-6β、C-7α、C-9α、C-14α羟基化以及C6-C7脱氢反应。根据薄层色谱图,发现最佳发酵条件为在25℃、pH值为5.0-6.5的条件下培养6天。时间进程研究表明,在发酵的第三天开始积累V和VI,第四天开始积累IV。在一批发酵中,能产生最大生物转化效率的底物最佳浓度为3.5mM。当浓度高于7.0mM时,生物转化完全受到抑制。